HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kuwait
Kuwait: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) was 100.0% in 2014. ▬ Flat
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kuwait, 2003–2014
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kuwait is 100.0%, measured in 2014. That is the highest value across all 10 years on record.
That represents a change of unchanged over ten years.
Over the whole period, hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kuwait peaked at 100.0% in 2003 and was at its lowest, 100.0%, in 2003.
Kuwait ranks 1st of 104 countries on this measure, in the top 10%.
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) in Kuwait, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 100.0% | — |
| 2004 | 100.0% | +0.0% |
| 2005 | 100.0% | +0.0% |
| 2006 | 100.0% | +0.0% |
| 2007 | 100.0% | +0.0% |
| 2008 | 100.0% | +0.0% |
| 2009 | 100.0% | +0.0% |
| 2010 | 100.0% | +0.0% |
| 2012 | 100.0% | +0.0% |
| 2014 | 100.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 100.0% | 7 |
| 2010s | 100.0% | 100.0% | 100.0% | 3 |
Countries ranked near Kuwait
- 1 Pakistan 100.0% compare
- 1 Sao Tome and Principe 100.0% compare
- 1 Lebanon 100.0% compare
- 1 Fiji 100.0% compare
- 1 Antigua and Barbuda 100.0% compare
- 1 Belize 100.0% compare
- 1 Egypt 100.0% compare
- 1 Mauritius 100.0% compare
- 1 Brunei Darussalam 100.0% compare
- 1 Oman 100.0% compare
- 1 Comoros 100.0% compare
- 1 Angola 100.0% compare
- 1 Saint Lucia 100.0% compare
- 1 Bangladesh 100.0% compare
- 1 Lesotho 100.0% compare
- 1 Timor-Leste 100.0% compare
- 1 Albania 100.0% compare
- 1 Morocco 100.0% compare
More health data for Kuwait
- Un projection of annual infant deaths, annual growth rate -0.9259 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.41 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 287.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 107 deaths (2100)
- Population ages 15-19, male, annual growth rate -1.51 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0293 units per person (2025)
- Population ages 20-24, female, annual growth rate 1.94 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0238 units per person (2025)
Frequently asked questions
- What is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kuwait?
- Hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) in Kuwait was 100.0% in 2014, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Kuwait?
- The highest recorded value was 100.0% in 2003.
- What is the lowest hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) recorded in Kuwait?
- The lowest recorded value was 100.0% in 2003.
- How does Kuwait rank for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Kuwait ranks 1st out of 104 countries with data for 2014.
- Is hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) rising or falling in Kuwait?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Kuwait data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).